Navigation Links
AutoGenomics Receives a Key European Patent for HPV Detection
Date:6/18/2008

CARLSBAD, Calif., June 18 /PRNewswire/ -- AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that it has been issued a key European patent for Human papillomavirus. Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims to be a method for detecting the presence of HPV using a microarray.

"This patent is the result of our collaboration with Dr. Erik Thunnissen, a prominent clinician and opinion leader in the field of Human papillomavirus," said Mr. Fareed Kureshy, President and CEO of AutoGenomics. He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory".

About AutoGenomics

AutoGenomics Inc., a privately held company based in Carlsbad, CA., has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the era of personalized medicine. http://www.autogenomics.com


'/>"/>
SOURCE AutoGenomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
2. Rutgers scientist receives prestigious Young Investigator Award
3. XTENT Announces CUSTOM I Data Receives Recognition from EuroIntervention
4. Denver Healths Dr. Patricia Gabow Receives NCHLs 2008 National Healthcare Leadership Award
5. Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets
6. Alexian Brothers Hospital Network Receives American Stroke Associations Get With The Guidelines Gold Performance Achievement Award
7. Mindrays AS3000(TM) Anesthesia Delivery System Receives U.S. FDA Clearance
8. Sam Schmidt Receives a Honda Odyssey Converted for Wheelchair Accessibility
9. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
10. Country Music Superstar, Sara Evans, Receives Red Cross National Award
11. ISI Receives New ISO 9001:2000 Certifications in California and New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... M ichael ... Chairman   Mission Therapeutics, a drug discovery ... to treat cancer, neurodegenerative and other diseases, announces that Dr ... effective January 1 st 2017. Dr Colin Goddard ... Director in July 2015. Michael Moore , Mission,s Founder ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016 Johnson & ... on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ... 7, 2016 through October 31, 2016 (the "Class Period"). ... designs, manufactures, and markets orthopaedic reconstructive products, such as knee ... ...
(Date:12/4/2016)... 2016  Results from the Phase II SUSTAIN study ... reduced the median annual rate of sickle cell-related pain ... 2.98, p=0.010) in patients with or without hydroxyurea therapy ... being featured in the official press briefing at the ... Meeting and presented during the Plenary Scientific Session tomorrow ...
Breaking Medicine Technology: